Nephros Inc. (NEPH) Stock Price, Quote & AI Analysis

Live NEPH stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Nephros Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Nephros Inc. (NEPH), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

NEPH
Nephros Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$45,801,003.73
52W Range
$1.39 - $6.42
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 4, 2026 Q4
After Hours
EPS Estimate: $0.0102
Revenue Estimate: $4,540,020.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Nephros Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Nephros Inc. Overview

Company information

Company Overview

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Company Details
Market Cap
$46.07M
Shares Outstanding
10,626,700
Weighted Shares Outstanding
10,626,683
CEO
Robert Banks
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
Employees
31
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Nephros Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...